Home
This site is intended for healthcare professionals
Advertisement
Share
Advertisement
Advertisement
 
 
 

Summary

In this comprehensive session, experts Dr. Joelle El Awar and Professor Emeritus Sir Arulkumaran Sabharatnam delve into essential topics for medical professionals, including various methods of contraception, toxic shock syndrome, and fertility and subfertility. The discussion covers natural and barrier contraception methods, hormonal contraception, emergency contraception options, and sterilization. It also includes facts about the combined oral contraceptive pill, discussing its reliability, mode of action, contraindications, advantages, and disadvantages, as well as guidance on use and potential side effects. Learn about the combined transdermal patch and vaginal contraceptive ring as well. This session is perfect for any health professional seeking up-to-date, comprehensive information on contraception options and considerations.

Generated by MedBot

Description

In this session we will cover all the different types of contraceptives used, their indications, mode of actions, contraindications, side effects to provide a comprehensive review of all the different contraceptives available, as per the UKMLA content map. We will also be covering toxic shock syndrome, a rare but serious disease, and finally we will go over Fertility, sub fertility and infertility - including the causes, investigations and managements.

Learning objectives

  1. Understand the various forms of contraception including natural methods, barrier methods, hormonal contraception, emergency contraception, intrauterine contraception, and sterilization procedures.
  2. Identify potential comorbidities that could impact the choice of contraception for the patients, such as hypertension, migraines, surgeries, allergies, lifestyle factors, reproductive history, and age.
  3. Understand the importance of assessing risks for sexually transmitted infections and advising patients on safe sex.
  4. Master the use of the UK Medical Eligibility Criteria (UKMEC) in order to assess a patient's eligibility for specific forms of contraception such as combined hormonal contraception (CHC), progestogen only pills (POP), and intrauterine contraceptives (IUC).
  5. Understand the risks, benefits, and side effects of each form of contraception, as well as the management of issues such as missed dosages, in order to provide comprehensive patient education.
Generated by MedBot

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

Contraception Presentedby DrJoelleElAwar,Obs andGynae Lead MTB and Subfertility ReviewedbyProfessor EmeritusSirArulkumaran SabharatnamConcepts • Contraception • Toxic Shock Syndrome • Fertility and Subfertility Contraception • Natural Method – Avoid sexual intercourse during fertile period (fertility awareness), Lactational amenorrhoea during breastfeeding, Coitus Interruptus – Unreliable • Barrier Method – Male condom, Female condom, Diaphragm, Cap + spermicide gel, sponge. • Hormonal contraception • Combined Hormonal Contraception (CHC) – COCP pill, Combined transdermal patch, Combined vaginal ring • Progestogen only – POP (pill), implant, injectable • Emergency Contraception- after unprotected sexual intercourse UPSI • Copper IUD - Gold standard • Ulipristal acetate (EllaOne) • Levonogestrel (Levonelle) • Intrauterine Contraception: Cu-IUD, LNG-IUS • Sterilization: Male (vasectomy) vs Female (tubal occlusion)Considerations • Exclude pregnancy – be reasonably certain • Identify any comorbidities • HTN, migraines, surgeries (gastric sleeve/bypass for oral medications), • Allergies (Latex..), Medications (esp liver enzyme inducing drugs, antiepileptics) • Lifestyle factors (smoking) • Reproductive history (postpartum, breastfeeding..) • Age (approaching menopause, <18 y o) • UKMEC should be applied to assess eligibility for CHC, POP of IUC • Assess risk for STIs, advice on safe sex • Risk assessment of sexual abuse, rape, non-consensual sex, <16 y o engaging in sexual intercourse (including capacity to consent, Fraser Criteria), any learning/physical disabilities.Combined Oral Contraceptive Pill • Reliable, Effective. If used correctly, 0.3% chance of pregnancy • Typical use - 9% chance of pregnancy • Modern COCP has ethinylestradiol (20,30, 25 mcg) + Progestogen, and most are monophasic (fixed dose) nd rd • Many types of progestogens : 2 gen (norethisterone, levonogestrel), 3 gen (Desogestrel, less androgenic), Yasmin (Drospirenone, antiandrogenic and weak antidiuretic), Co-cyprindiol/Dianette : Cyproterone acetate, anti androgenic (used in PCOS) • Mode of Action • Ovulation inhibition (-ve feedback on Hypothalamus and pituitary) —> Lower LH and FSH, no LH surge, no ovulation • Thickened cervical mucus, prevents sperm penetration • Thin endometrium, preventing implantation and prevent endometrial hyperplasiaContraindications - UKMEC • UKMEC 4 – Unacceptable Risk,Absolute CI • >35 y o with >15 cig/day • Migraine with aura • History of VTE/Stroke/IHD, severe diabetes, uncontrolled HTN, major surgery, prolonged immbolisation • Breastfeeding <6 weeks postpartum, known/suspected pregnancy • Current Breast Ca • UKMEC 3 – Disadvantage >> Benefits • >35 y o with <15 cig/day, BMI>35, Fam Hx VTE in 1 degree relative <45 y o , diabetes, controlled HTN, Immobility, BRCA ½ +ve, Current gallbladder disease, >6weeks postpartum • UKMEC 2 – Advantages generally outweighs disadvantages • Comorbidities, BMI 30-34 • UKMEC 1 – No restriction for usePill T each • If pill started between days 1-5 of period—> Contraception immediate • If started later, Contraception needed for 7 days • Not suitable if taking with liver enzyme-inducing medication as it decreases its efficacy • Taken at the same time every day • Either one pill daily for 21 days, then 7 pill free days. Or Continuous pills with one week being placebo pill. • After Emergency contraception, start COCP • Immediately after levonogestrel • 5 days after ulipristal acetate • Avoid intercourse or use barrier protection for the next 7 days • Golden Rule • COCP needs 7 continuous days to start protecting!! Missed Pill • If 1 pill missed: Take one ASAP + today’s one. • If <72 hrs since last pill, that’s it. No need for more precautions. • If 2 or more missed (>72 hrs) • In Week 1: Take ASAP + 7 days of barrier condoms + emergency contraception if UPSI occurred. • In Week 2 : Continue, 7 days protection, NO need for emergency pill. • In Week 3: Take & Omit pill free interval / placebo week & needednew pack, 7 days protection, no extra emergency pill • >7 pills missed —> Emergency contraception + 7 days condoms +/- Pregnancy test + restart COCP Advantagesvs Disadvantages • Advantages • Disadvantages • Reduce menstrual blood loss & pain, regulates • Increases risk of VTE, PE, Strokes and cycle cardiovascular disease • Reduced risk of benign ovarian cysts and • Small increased risk of breast cancer tumours • No protection against STIs • Reduces incidence of PID • May be forgotten • Improves skin condition in acne vulgaris • Reduces symptoms like PMS and endometriosis • Progesterone implants/Injectables)S, • Reduces risk of colorectal cancer and ovarian cancer • More effective than barrier contraception • Easily reversible, normal fertility immediately after stoppingSide Effects • Nausea, Abdominal pain • Menstrual Irregularities • Twice increased risk of stroke (esp in diabetes, smoke..) • Cervical cancer (risk x 2 after 10 yrs, return to normal after 10 yrs of stopping) • Liver Disease • Headache • HTN • VTE (small increase) • Meningioma, Angioedema • Breast pain & tenderness • Change in lipid metabolism • Breast cancer (small, and goes back to normal after 10 yrs of stopping)Combined Transdermal Patch • Start on day 1-5 of menstrual cycle, otherwise +7days of barrier • Can start immediately after COCP, combined vaginal ring, same for switching from POP or LNG-IUS. • After emergency contraception - can start immediately after levonogestrel and 5 days after ulipristal acetate • Cu-IUD • Remove on day 1-5 of menstrual cycle, start CTP on same day. No additional contraception needed. • Can start CTP 7 days before IUD removal, no extra contraception. • If removed any other time avoid UPSI & use barrier for 7 days • Postpartum • Non-Breastfeeding – start after 21 days • Breastfeeding - start >6weeks• Evra patch – Norelgestromin (Progestogen) + Ethinylestradiol • Replaced weekly for 3 weeks + 1 patch free week (induce withdrawal bleed). Can start new patch even if still bleeding • Same mode of action, side effects, indications, contraindications and effectiveness as COCP • Minor skin irritation • Less effective if >90 kg • More convenient than a pill every day • If detached, put new one (<48 hrs). If >48 hrs, 7 days protection • Stop 4 weeks before major surgery/immobilisation, stop at 50 y oCombined V aginal Ring – Nuva Ring • Flexible, latex free, transparent, colourless • Etonogestrel and ethinyloestradiol, over 21 days, then removed for 7 days • Insert on day 1-5 of cycle, otherwise +7 days of protection • Post emergency contraception: start immediately after levonorgestrel, or 5 days after ulipristal acetate (+7 days protection) • Postpartum: On day 21 if not breastfeeding, or >6 weeks if breastfeeding • Same MOA, SE, Indication & CI & effectiveness as COCPProgesterone Only Pill • Levonorgestrel, Norethisterone, Desogestrel, Drospirenone • Mode of Action • Thickened cervical mucous, preventing sperm penetration • Delay ovum transport • Inhibit ovulation • Hostile endometrium to implantation • Perfect use: 0.3% pregnancy per year, typical use 9% • Taken daily, no pill-free interval • Ideal when COCP contraindicatedPill T each • Take pill daily, no pill free interval, at the same time every day • Forgotten, vomit within 2 hrs of ingestion or watery diarrhoea —> Missed pill rule • If taken >3 hrs late (>12 hrs for desogestrel, or >24 hrs for drospirenone) also considered mised • Take missed pill asap & subsequent pill at usual time • Take extra precaution over next 2 days • Stop if postmenopausal or >55 y oSide Effects • Following emergency contraception • Menstrual irregularities (prolonged, • Start immediately after breakthrough) – common levonorgestrel • Ectopic pregnancy • Start 5 days after ulipristal acetate • Breast tenderness • Ovarian cyst • Libido changes • Depression, mood changes • Contraindications:Active cancer, • Panic attacks pregnancy, active hepatic disease, severe arterial disease, undiagnosed • Headaches and migraines PV bleed. Caution as interacts with • Weight changes liver enzyme-inducing drugsProgesterone Only Implant • Subdermal Nexplanon (etonogestrel) • Lasts 3 years • Local anaesthetic, placed on days 1-5 of cycle. • If >day 5, use 7 days protection • Be reasonably certain patient not pregnant • May need emergency contraception, pregnancy test • Start immediately post-partum if <21 days • Same MOA, Indications, CI, SE &Interactions as POP • Implant may break, migrate • Some complications during insertion & removal may occur • Also remove at 55Progesterone Only Injectable • Day 1-5 of menstrual cycle, barrier for 7 days • Same as all previous progesterone only options. • Depo Provera – Deep IM every 12 weeks • Synapress - SC every 13 weeks, Noristerat - Deep IM twice, 8 weeks apart • If UPSI > 14 weeks (or >10 for Noristerat) – consider emergency contraception, mainly Cu-IUD or Levonorgestrel • Ulipristal acetate may be less effective due to residual progestogen • SE : Menstrual irregularities, Weight gain, mood changes, injection site reaction, small loss in bone density, small increased risk in breast and cervical cancer (if used for >5 yrs) • Review every 2 yrs, review risk of osteoporotic fractures • Stop at 50 y oEmergency Contraception • Indications: UPSI, Barrier failure, patch removal, ring detachment, missed pills, late injections, expired implants… • 3 options currently (in the UK) • Copper intrauterine device (Cu-IUD) – inserted within 5 days of UPSI, or within 5 days of earliest estimated date of ovulation. Usually first line. • Not Mirena!! • Oral ulipristal acetate (30 mg) – Within 5 days after UPSI, or contraceptive failure, or within 5 days before earliest likely date of ovulation • Oral levonorgestrel (1.5 mg) - Within 72 hrs after UPSI/Contraceptive failure • If multiple UPSI or >5 days or woman unsure —> Oral Ulipristal acetate First line • There is no evidence that oral EC is effective if ovulation already occurredCopper IUD • Emergency and regular contraception • Inhibits fertilisation by direct toxicity, inhibit sperm transport, induce inflammatory reaction in endometrium • Can be removed any time, No STI protection • Be reasonably certain woman is not pregnant • Adverse effects: Painful insertion, bleeding, uterine perforation, expulsion, PID, ectopic pregnancy • Insert within 48 hrs of delivery of >4 weeks • DO NOT insert in active PID, distorted uterus, copper allergy, pregnancy and undiagnosed bleeding • Can last 5 to 10 years, but must be removed at 55 and should not be left if not neededUlipristal Acetate • Progesterone receptor modulator • Within 120 hrs of UPSI • Delays ovulation for at least 5 days, even after LH surge • May impair effectiveness of progestogen containing contraceptive for the rest of the cycle • SE: GI disturbance, menstrual irregularities, ectopic pregnancy, mood disorder, pelvic pain, breast tenderness • Delay breastfeeding for 1 week & COCP for 5 daysLevonorgestrel (LNG) • Up to 72 hrs after UPSI • Inhibits ovulation for next 5 days. If late – ineffective, & effectiveness decreases with time • SE : Headache, GI disturbance, ectopic pregnancy, breast tenderness • BMI >26 or >70kg – Double dose • Unlike Cu-UID, Ulipristal & LNG do not offer contraception for the remainder of the cycle & subsequent UPSI. They should also be used occasionally rather than regular, as they are not recommended multiple times in a cycleIntrauterine Systems • Cu-IUD (discussed in Emergency contraception) • Levonorgestrel Releasing System, Mirena IUS • Reversible, highly effective. Either on Days 1-5 for immediate protection or at any time + extra 7 days of protection • Decreases menstrual blood loss – used in management of dysmenorrhea and AUB. Periods usually lighter, shorter and less painful • Endometrial atrophy and prevents implantation • Thickens cervical mucous, inhibits sperm penetration • Ovulation usually preserved • Useful if Oestrogen CI • Postpartum within 48 hrs or >4 weeks postpartum • SE: Irregular PV bleed, hormonal symptoms, perforation & expulsionSpecial considerations in contraception • Fibroids causing uterine distortion —> No Cu-IUD & LNG-IUS • Current PID —> No Cu-IUD & LNG-IUS • High risk of VTE, CVD , HTN or migraine with aura —> Do not use combined hormonal contraception (pill, patch or ring) • Idiopathic menorrhagia —> IUS first line • If taking teratogenic drugs (Warfarin, lithium, sodium valproate) —> Use LARCs as most effective (IUS or implant) • >35 y o, smokes >15 cig/day —> do not use CHC. Caution in smokers in general • Lamotrigine —> Avoid CHC (reduces its effectiveness), but POP increase lamotrigine levelsT oxic Shock Syndrome • Exotoxin mediated multisystemic illness – Strep Aureus & MRSA • Leads to shock and multi organ failure • Associated with tampon use, relatively rare (3/100,000) • S&S (within hours) : Fever, N&V, Widespread rash >90% body surface with desquamation, Hypotension, multiorgan dysfunction (renal, liver, coagulopathy, ARDS), Myalgia, myositis, soft tissue necrosis • Inv: Cultures, wound swabs, FBC (Low Plt, leukocytosis), elevated CK, LFTs • Tx:As Sepsis 6 • Aggressive fluid and electrolyte resuscitation, address source of infection (abscess, tampon, wound..), • Antibiotics (Clinda + Ceph/meropenem/vancomycin), may use steroids • Surgical debridement • Complications • AKI, ARDS, Hepatic necrosis, metabolic acidosis, DIC, Encephalopathy, Rhabdomyolysis, cardiomyopathy, Recurrence (30-40%), Death (5-15%) Fertility & Subfertility • 84% of couples in the general population conceive naturally within 1 year, if they have regular (every 2-3 days) UPSI, and 92% after 2 years. • 1 in 7 couples have difficulty convceiving (in the UK) • Infertility – trying without success • Primary – never conceived, or Secondary- previously conceived • Subfertility – Reduced fertility, prolonged duration of unwanted lack of conception • Main causes: Ovulatory disorders (25%), tubal damage (20%), male infertility (30%), uterine/peritoneal disease (10%) • No identifiable cause in 25% of couples • Disorders in both man and woman – 40% of infertile couples • Other lifestyle factors (drugs, stress, obesity, smoking, alcohol), embryo defects and pelvic conditions can also be of significanceInfertility in Men • No underlying cause / idiopathic – 44% of cases • All tests normal, past medical history insignificant • Semen analysis (between 2-7 days of abstinence) • Check volume, pH, sperm concentration/motility/morphology • Decreased number of spermatozoa – oligozoospermia • Decreased sperm motility – asthenozoospermia • Many abnormal sperm morphology – teratozoospermia • Identifiable causes • Primary spermatogenic disorder, • Genetic disorders – Kallman, Klinefelter, androgen insensitivity syndrome • Obstructive azoospermia (obstructed ducts), Varicocele, Hypogonadism, Cryptorchidism (undescended testes), Vasectomy, infection, lifestyle factors, medication/drugs.. • STI screening useful (Chlamydia)Infertility in Women • Ovulatory Disorders • Group I - hypogonadotrophic hypogonadism, caused by Hypothalamic pituitary failure (10%) • Hypothalamic amenorrhoea – low body weight, excessive exercise • Congenital (Kallmann, unknown) • Present with amenorrhoea • Group II – Hypothalamic - Pituitary – Ovarian dysfunction (85%, most common) • PCOS, Hyperprolactinaemic amenorrhoea • Group III – Ovarian Failure (4-5%) • Menopausal symptoms, <40 y o • Idiopathic, post chemotherapy/radiotherapy, Post oophorectomy • High gonadotrophins, Raised FSH (>30), Low Oestradiol – Treat as menopause • Other causes: Hypo/hyperthyroid, Adrenal abnormalities (Cushing’s, Congenital adrenal hyperplasia, Cancers, AIDS, STI/PID, endometriosis, fibroids, Ashermann, Drugs, Age, lifestyle…Treatment • Full detailed history from both man and woman, examination for both • Lifestyle changes, Regular UPSI • Investigate if fail to conceive >1 year, earlier if known pathology/surgery.. • Investigations for women • Mid-luteal phase progesterone (to confirm ovulation) – 7 days before expected period, >30 Indicates ovulation • STI screen, FSH/LH, TFT, prolactin • May need tubal patency test, diagnostic laparoscopy and dye • Tx • Medical – Clomifene, Gonadotrophins, Pulsatile GnRH and dopamine agonist, PCOS tx • Surgical – Tubal Microsurgery, Ablation/excision of endometriosis • If all fails, ART – Insemination, IVF, Donor sperm/eggs, embryo donation, Surrogacy…Please fill the feedback form to get your certificate of attendance ☺ https://app.medall.org/feedback/feedback- flow?keyword=048208424eaa06be4cb1c8ef&organisation=mind-the-bleep